NCT01572701View on ClinicalTrials.gov

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

99mTc-MIP-1404

20 (±3) mCi of study drug will be administered by IV injection as a slow bolus and flushed with approximately 10 mL of saline

Trial Locations (1)

10065

Weill Cornell Medical College, New York

Sponsors
All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY